Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
35
self-reported band not used
Founded
2004
22 years
Legal entities
None matched
Office countries
3
5 addresses
Funding rounds
1
Series unknown · Jul 2022 · US$ 70.0M
Company type
Privately Held
self-reported
Description
Evive Biotech is a global biopharmaceutical company devoted to developing a portfolio of novel biological therapies for patients worldwide. We leverage our proprietary technology platforms to advance a series of innovative drug candidates for oncology, inflammatory and metabolic diseases.
Founded in 2004, we currently have operations in the US, Singapore, and China. As the first biopharmaceutical company to build a platform bringing innovative therapies from China to the world, Evive adopts a holistic approach to drug development, combining exceptional research and commercialization capabilities with our world-class in-house regulatory expertise and extensive international management experience.
Through partnerships with industry, physicians, and regulatory authorities, we strive to bring revolutionary remedies to the global market quickly and efficiently to address unmet medical needs, making a real and lasting difference to patients and their families worldwide.
To learn more, visit www.evivebiotech.com.
Specialties
All 4 specialties
- Research & Development
- Biopharmaceutical
- Innovation
- Pharmaceutical
Related specialties
Locations
3
Countries with an office address5 addresses on record
Country footprint
Show as table · Offices in 3 countries
| Countries | 3 |
|---|---|
| Primary country | SG |
All codes: SG CN US
Addresses
- SGSingaporePrimary
- CNBeijing
- USNew Jersey
- CNShanghai
- USSan Francisco Bay Area
Grid intelligence Members
Funding
Last round · 2 July 2022US$ 70.0MSeries unknown
Rounds1
Round typeSeries unknown · venture round
Amount (USD)70,000,000
Stage ranknot recorded
Investors named0
Since last round3 yr 6 mo
Funding
Show as table · 1 funding round
| Rounds | 1 |
|---|---|
| Axis | 2004 to 2026 |
| Series unknown · 2 Jul 2022 | US$ 70.0M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
How many people work at Evive Biotech?
The record holds 35 counted staff profiles at January 2026. Its self-reported band sits above that count and is not published as a headcount.
Where does Evive Biotech have offices?
Five addresses on record across 3 countries. Primary: Singapore.
Has Evive Biotech raised funding?
One round. Latest 2 July 2022: Series unknown, US$70,000,000.
What does Evive Biotech list as its specialties?
Four tags on the brand's own list, among them research & development, pharmaceutical and innovation.
Which companies are listed alongside Evive Biotech?
2 profiles list Evive Biotech as a peer — 43rd percentile in Biotechnology. It lists ten peers of its own.